All AbMole products are for research use only, cannot be used for human consumption.
Ebselen (SPI-1005) is a potent voltage-dependent calcium channel (VDCC) blocker. Ebselen potently inhibits Mpro (IC50=0.67 μM) and COVID-19 virus (EC50=4.67 μM). Ebselen is also an inhibitor of HIV-1 capsid CTD dimerization. Ebselen can permeate the blood-brain barrier and has anti-inflammatory, antioxidant and anticancer activity.
| Molecular Weight | 274.18 |
| Formula | C13H9NOSe |
| CAS Number | 60940-34-3 |
| Solubility (25°C) | DMSO 40 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
[4] H Sies. Free Radic Biol Med. Ebselen, a selenoorganic compound as glutathione peroxidase mimic
| Related Calcium Channel Products |
|---|
| Diltiazem
Diltiazem is an orally active L-type Ca2+ channel blocker. Diltiazem shows antihypertensive and antiarrhythmic effects. |
| L-Phenylalanine-d8
L-Phenylalanine-d8 is the deuterium labeled L-Phenylalanine. L-Phenylalanine is a α2δ subunit of voltage-dependent Ca+ channels antagonist with a Ki of 980 nM. |
| CBD3063
CBD3063 is a selective, first-in-class, CRMP2-based peptidomimetic small molecule, which allosterically regulates Cav2.2 to achieve analgesia and pain relief without negative side effect profiles. |
| TTA-A8
TTA-A8 is a short-acting T-type calcium channel antagonist with oral activity, exhibiting an IC50 value of 31.3 nM in the FLIPR depolarization assay. |
| MONIRO-1
MONIRO-1 is a T-type and N-type calcium channel blocker with IC50 values of 34, 3.3, 1.7 and 7.2 µM against hCav2.2, hCav3.1, hCav3.2 and hCav3.3, respectively. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
